Position in ALNY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$833,853
-$63,135 QoQ
Shares Held
2,770
+2.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#420
of 786 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $19,777,074 across 42 Biotechnology names. ALNY ranks #4 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,514 | $3,438,199 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,474 | $3,215,830 | |
| 3 | INCY |
Incyte Corp
|
7,759 | $879,560 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
2,770 | $833,853 | |
| 5 | ARGX |
Argenx SE
|
809 | $750,565 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
3,045 | $733,753 | |
| 7 | TWST |
Twist Bioscience Corp
|
6,969 | $716,970 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
27,134 | $686,490 |
All Filings in ALNY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $833,853 | 2,770 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $896,988 | 2,711 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,023,948 | 2,575 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,260,384 | 2,764 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,435,774 | 4,403 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,129,223 | 4,182 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,117,251 | 4,748 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,201,881 | 4,370 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $755,487 | 3,109 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||